Reporting owner · Q3 2026 · CIK 1190128

Tobin James R: insider trades.

Tobin James R reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($2.2M), across 2 companies.

Transactions
4
Purchases (P)
0
Sales (S)
1
Companies
2
Name as filed
TOBIN JAMES R

Companies

CompanyRelationshipTransactions
Globus Medical Inc (GMED)Director3
TransMedics Group, Inc. (TMDX)Director1

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-15Globus Medical IncM15,000$53.7515,000Form 4
2026-09-15Globus Medical IncM15,000$63.6830,000Form 4
2026-09-15Globus Medical IncS30,000$74.580Form 4
2026-08-17TransMedics Group, Inc.G18,000$00Form 4

Questions

What stock did Tobin James R buy or sell?

Tobin James R reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($2.2M), across 2 companies.

Is Tobin James R the same person as other filers with this name?

This page covers SEC CIK 1190128 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/tobin-james-r-1190128.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.